A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 39855942.
- Also identified by DOI 10.1016/j.eururo.2025.01.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neoadjuvant systemic treatment strategies have improved outcomes in several solid tumour types. This success has not yet been replicated in renal cell carcinoma (RCC). A consensus and international collaboration are urgently needed for the development of adaptive perioperative immunotherapy strategies for patients with RCC at high risk of recurrence.
Medical subject headings
- Kidney Neoplasms
- Neoadjuvant Therapy
- Carcinoma, Renal Cell